Insider Trading (SEC Form 4)


Insiders are officers, directors, or significant investors. This page shows recent insider transactions for Drugs.

Transaction
Date
CompanyInsider Code
(see below)
Shares Post Shares Percent
Change
Share
Price
Tran
Value
Post
Value
Percent
Change
2019-12-29 LPTN H.I.G. Ventures - Endosurgery, LLC ( 10% Owner) J 1,451,185 1,451,185
2019-12-29 LPTN Remeditex Ventures LLC ( 10% Owner) J 1,309,392 1,309,392
2017-11-21 MGNX Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO) M 5,000 35,000 16.67 4.70 23,500
2017-11-21 COLL Fleming Alison B (Chief Technology Officer) M 572 26,295 2.22 0.28 160
2017-11-21 USNA Gull Global Ltd ( 10% Owner) S -117,270 11,739,269 -0.99 66.5285 -7,801,797 780,995,958 -1.00
2017-11-21 USNA WENTZ MYRON W ( Director) S -117,270 11,739,269 -0.99 66.5285 -7,801,797 780,995,958 -1.00
2017-11-21 MNTA WHEELER CRAIG A (President & CEO Director) S -2,058 635,129 -0.32 13.34 -27,454 8,472,621 -0.32
2017-11-21 MNTA WHEELER CRAIG A (President & CEO Director) S -2,058 633,071 -0.32 13.35 -27,474 8,451,498 -0.33
2017-11-21 MNTA Kaundinya Ganesh Venkataraman (COO & CSO) S -396 487,633 -0.08 13.15 -5,207 6,412,374 -0.08
2017-11-21 MNTA Kaundinya Ganesh Venkataraman (COO & CSO) S -425 487,208 -0.09 13.15 -5,589 6,406,785 -0.09
2017-11-21 MNTA Leicher Bruce (SVP & General Counsel) S -416 172,906 -0.24 13.15 -5,470 2,273,714 -0.24
2017-11-21 MNTA Leicher Bruce (SVP & General Counsel) S -387 172,519 -0.22 13.15 -5,089 2,268,625 -0.22
2017-11-21 MGNX Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO) S -5,000 30,000 -14.29 20 -100,000 600,000 -16.67
2017-11-21 AMPH Gerst Diane G. (EVP, QA & Regulatory Affairs) S -523 31,733 -1.62 18.8131 -9,839 596,996 -1.65
2017-11-21 PIP SCHAFFER DERACE L ( Director) P 7,236 252,428 2.95 2.0599 14,905 519,976 2.87
2017-11-21 COLL Fleming Alison B (Chief Technology Officer) S -572 25,723 -2.18 19.00 -10,868 488,737 -2.22
2017-11-20 RGNX Mills Kenneth T. (President and CEO Director) M 30,000 128,530 30.45 0.85 25,500
2017-11-20 EDIT Hack Andrew A. F. (Chief Financial Officer) M 5,000 5,000 3.23 16,150
2017-11-20 IMMU MARKISON BRIAN A ( Director) M 15,000 99,178 17.82 3.16 47,400
2017-11-20 GILD BISCHOFBERGER NORBERT W (EVP, R&D and CSO) G -10,000 2,308,407 -0.43
2017-11-20 BCLI Rubin Eyal (CFO and Treasurer) A 25,000 25,000
2017-11-20 LLY MARRAM ELLEN R ( Director) A 1,924 53,071 3.76 83.18 160,038
2017-11-20 LLY Alvarez Ralph ( Director) A 2,055 39,153 5.54 83.18 170,935
2017-11-20 LLY SEIFERT KATHI P ( Director) A 1,924 68,217 2.90 83.18 160,038
2017-11-20 LLY PRENDERGAST FRANKLYN G ( Director) A 802 68,574 1.18 83.18 66,710
2017-11-20 LLY TAI JACKSON P ( Director) A 1,924 50,899 3.93 83.18 160,038
2017-11-20 LLY ESKEW MICHAEL L ( Director) A 1,924 36,811 5.51 83.18 160,038
2017-11-20 LLY Bertozzi Carolyn R ( Director) A 1,763 1,763 83.18 146,646
2017-11-20 LLY Runge Marschall S ( Director) A 1,924 9,283 26.14 83.18 160,038
2017-11-20 LLY JACKSON JAMERE ( Director) A 1,924 2,455 362.34 83.18 160,038
2017-11-20 LLY Kaelin William G Jr ( Director) A 1,924 13,448 16.70 83.18 160,038
2017-11-20 LLY LUCIANO JUAN R ( Director) A 2,040 5,183 64.91 83.18 169,687
2017-11-20 LLY Baicker Katherine ( Director) A 1,924 14,923 14.80 83.18 160,038
2017-11-20 LLY Fyrwald J Erik ( Director) A 1,924 57,760 3.45 83.18 160,038
2017-11-20 LLY HOOVER R DAVID ( Director) A 1,924 37,784 5.37 83.18 160,038
2017-11-20 USNA Gull Global Ltd ( 10% Owner) S -39,751 11,856,539 -0.33 66.1129 -2,628,054 783,870,177 -0.34
2017-11-20 USNA WENTZ MYRON W ( Director) S -39,751 11,856,539 -0.33 66.1129 -2,628,054 783,870,177 -0.34
2017-11-20 BGNE Huang Jane (CMO, Hematology) S -1,000 266,000 -0.37 87 -87,000 23,142,000 -0.38
2017-11-20 NATR WYNNEFIELD PARTNERS SMALL CAP VALUE LP ( 10% Owner) WYNNEFIELD PARTNERS SMALL CAP VALUE LP I ( 10% Owner) WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND LTD ( 10% Owner) Wynnefield Capital, Inc. Profit Sharing Plan ( 10% Owner) WYNNEFIELD CAPITAL MANAGEMENT LLC ( 10% Owner) WYNNEFIELD CAPITAL INC ( 10% Owner) OBUS NELSON ( 10% Owner) LANDES JOSHUA ( 10% Owner) P 2,270 1,508,617 0.15 11.70 26,559 17,650,819 0.15
2017-11-20 NATR WYNNEFIELD PARTNERS SMALL CAP VALUE LP ( 10% Owner) WYNNEFIELD PARTNERS SMALL CAP VALUE LP I ( 10% Owner) WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND LTD ( 10% Owner) Wynnefield Capital, Inc. Profit Sharing Plan ( 10% Owner) WYNNEFIELD CAPITAL MANAGEMENT LLC ( 10% Owner) WYNNEFIELD CAPITAL INC ( 10% Owner) OBUS NELSON ( 10% Owner) LANDES JOSHUA ( 10% Owner) P 1,069 687,249 0.16 11.70 12,507 8,040,813 0.16
2017-11-20 RGNX Mills Kenneth T. (President and CEO Director) S -10,000 118,530 -7.78 27.71 -277,100 3,284,466 -8.44
2017-11-20 ENDV Mann Michael Scott (President 10% Owner) P 3,000 24,252,189 0.01 0.057 171 1,382,375 0.01
2017-11-20 ENDV Mann Michael Scott (President 10% Owner) P 3,000 24,249,189 0.01 0.057 171 1,382,204 0.01
2017-11-20 ENDV Mann Michael Scott (President 10% Owner) P 3,000 24,246,189 0.01 0.055 165 1,333,540 0.01
2017-11-20 ENDV Mann Michael Scott (President 10% Owner) P 3,000 24,243,189 0.01 0.051 153 1,236,403 0.01
2017-11-20 ENDV Mann Michael Scott (President 10% Owner) P 3,000 24,240,189 0.01 0.05 150 1,212,009 0.01
2017-11-20 ENDV Mann Michael Scott (President 10% Owner) P 3,000 24,237,189 0.01 0.0449 135 1,088,250 0.01
2017-11-20 IMMU MARKISON BRIAN A ( Director) S -8,390 90,788 -8.46 11.8860 -99,724 1,079,106 -9.24
2017-11-20 PCRX Jones James B (SVP & Chief Medical Officer) S -850 16,823 -4.81 41.1088 -34,942 691,573 -5.05
2017-11-20 PIP SCHAFFER DERACE L ( Director) P 4,800 245,192 2.00 2.0745 9,958 508,651 1.96
A
Grant, award, or other acquisition of securities from the company (such as an option)
K
Equity swaps and similar hedging transactions
P
Purchase of securities on an exchange or from another person
S
Sale of securities on an exchange or to another person
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
M
Exercise or conversion of derivative security received from the company (such as an option)
G
Gift of securities by or to the insider
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)